0 XP   0   0   0

Braster S.A.
Buy, Hold or Sell?

Should you buy, hold or sell Braster?

I guess you are interested in Braster S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Braster

Let's start. I'm going to help you getting a better view of Braster S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Braster S.A. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Braster S.A. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Braster S.A.. The closing price on 2023-01-31 was zł0.74 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Braster S.A. Daily Candlestick Chart
Braster S.A. Daily Candlestick Chart
Summary









1. Valuation of Braster




Current price per share

zł0.74

2. Growth of Braster




Is Braster growing?

Current yearPrevious yearGrowGrow %
How rich?$136.4k$1.8m-$1.5m-444.0%

How much money is Braster making?

Current yearPrevious yearGrowGrow %
Making money-$305.9k-$823.6k$517.6k169.2%
Net Profit Margin-1,308.9%-12,722.2%--

How much money comes from the company's main activities?

3. Financial Health of Braster




Comparing to competitors in the Medical Devices industry




  Industry Rankings (Medical Devices)  


Richest
#351 / 390

Most Revenue
#322 / 390

Most Profit
#169 / 390

Most Efficient
#345 / 390


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Braster S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Braster earns for each zł1 of revenue.

  • Above 10% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • A Net Profit Margin of -101.8% means that zł-1.02 for each zł1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Braster S.A.:

  • The MRQ is -101.8%. The company is making a huge loss. -2
  • The TTM is -1,308.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-101.8%TTM-1,308.9%+1,207.1%
TTM-1,308.9%YOY-12,722.2%+11,413.3%
TTM-1,308.9%5Y-5,093.1%+3,784.1%
5Y-5,093.1%10Y-3,620.0%-1,473.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.8%-16.2%-85.6%
TTM-1,308.9%-15.7%-1,293.2%
YOY-12,722.2%-15.1%-12,707.1%
5Y-5,093.1%-22.6%-5,070.5%
10Y-3,620.0%-24.7%-3,595.3%
1.1.2. Return on Assets

Shows how efficient Braster is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • -3.6% Return on Assets means that Braster generated zł-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Braster S.A.:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-5.6%+2.0%
TTM-5.6%YOY-10.0%+4.3%
TTM-5.6%5Y-7.5%+1.9%
5Y-7.5%10Y-7.5%+0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-2.9%-0.7%
TTM-5.6%-2.8%-2.8%
YOY-10.0%-2.2%-7.8%
5Y-7.5%-3.6%-3.9%
10Y-7.5%-3.5%-4.0%
1.1.3. Return on Equity

Shows how efficient Braster is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • -142.7% Return on Equity means Braster generated zł-1.43 for each zł1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Braster S.A.:

  • The MRQ is -142.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -98.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-142.7%TTM-98.0%-44.7%
TTM-98.0%YOY-49.7%-48.3%
TTM-98.0%5Y-38.4%-59.6%
5Y-38.4%10Y-26.3%-12.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.7%-3.2%-139.5%
TTM-98.0%-3.6%-94.4%
YOY-49.7%-1.9%-47.8%
5Y-38.4%-4.0%-34.4%
10Y-26.3%-4.3%-22.0%

1.2. Operating Efficiency of Braster S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Braster is operating .

  • Measures how much profit Braster makes for each zł1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • An Operating Margin of -60.8% means the company generated zł-0.61  for each zł1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Braster S.A.:

  • The MRQ is -60.8%. The company is operating very inefficient. -2
  • The TTM is -1,066.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-60.8%TTM-1,066.1%+1,005.3%
TTM-1,066.1%YOY-11,751.6%+10,685.5%
TTM-1,066.1%5Y-4,646.9%+3,580.8%
5Y-4,646.9%10Y-3,369.8%-1,277.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.8%-15.2%-45.6%
TTM-1,066.1%-14.2%-1,051.9%
YOY-11,751.6%-11.0%-11,740.6%
5Y-4,646.9%-20.2%-4,626.7%
10Y-3,369.8%-22.3%-3,347.5%
1.2.2. Operating Ratio

Measures how efficient Braster is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are zł1.48 for each zł1 in net sales.

Let's take a look of the Operating Ratio trends of Braster S.A.:

  • The MRQ is 1.484. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.554. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.484TTM4.554-3.069
TTM4.554YOY34.843-30.290
TTM4.5545Y28.367-23.813
5Y28.36710Y23.327+5.040
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4841.418+0.066
TTM4.5541.283+3.271
YOY34.8431.231+33.612
5Y28.3671.325+27.042
10Y23.3271.289+22.038

1.3. Liquidity of Braster S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Braster is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.33 means the company has zł0.33 in assets for each zł1 in short-term debts.

Let's take a look of the Current Ratio trends of Braster S.A.:

  • The MRQ is 0.326. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.346. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.326TTM0.346-0.020
TTM0.346YOY0.529-0.183
TTM0.3465Y1.018-0.671
5Y1.01810Y2.711-1.693
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3263.491-3.165
TTM0.3463.832-3.486
YOY0.5293.480-2.951
5Y1.0183.545-2.527
10Y2.7113.273-0.562
1.3.2. Quick Ratio

Measures if Braster is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Braster to the Medical Devices industry mean.
  • A Quick Ratio of 0.05 means the company can pay off zł0.05 for each zł1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Braster S.A.:

  • The MRQ is 0.051. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.044. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.051TTM0.044+0.006
TTM0.044YOY0.087-0.042
TTM0.0445Y0.403-0.358
5Y0.40310Y1.873-1.470
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0511.723-1.672
TTM0.0442.035-1.991
YOY0.0871.879-1.792
5Y0.4031.805-1.402
10Y1.8731.775+0.098

1.4. Solvency of Braster S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Braster assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Braster to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.97 means that Braster assets are financed with 97.5% credit (debt) and the remaining percentage (100% - 97.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Braster S.A.:

  • The MRQ is 0.975. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.937. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.975TTM0.937+0.038
TTM0.937YOY0.787+0.150
TTM0.9375Y0.645+0.292
5Y0.64510Y0.468+0.177
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9750.339+0.636
TTM0.9370.350+0.587
YOY0.7870.438+0.349
5Y0.6450.467+0.178
10Y0.4680.472-0.004
1.4.2. Debt to Equity Ratio

Measures if Braster is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Braster to the Medical Devices industry mean.
  • A Debt to Equity ratio of 3,865.2% means that company has zł38.65 debt for each zł1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Braster S.A.:

  • The MRQ is 38.652. The company is unable to pay all its debts with equity. -1
  • The TTM is 19.069. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ38.652TTM19.069+19.583
TTM19.069YOY4.476+14.594
TTM19.0695Y5.357+13.713
5Y5.35710Y3.161+2.196
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ38.6520.462+38.190
TTM19.0690.462+18.607
YOY4.4760.581+3.895
5Y5.3570.632+4.725
10Y3.1610.688+2.473

2. Market Valuation of Braster S.A.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every zł1 in earnings Braster generates.

  • Above 15 is considered overpriced but always compare Braster to the Medical Devices industry mean.
  • A PE ratio of -24.39 means the investor is paying zł-24.39 for every zł1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Braster S.A.:

  • The EOD is -24.519. Company is losing money. -2
  • The MRQ is -24.387. Company is losing money. -2
  • The TTM is -20.646. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-24.519MRQ-24.387-0.133
MRQ-24.387TTM-20.646-3.741
TTM-20.646YOY-20.493-0.154
TTM-20.6465Y-17.117-3.529
5Y-17.11710Y-127.846+110.729
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-24.519-6.306-18.213
MRQ-24.387-6.896-17.491
TTM-20.646-11.813-8.833
YOY-20.493-10.927-9.566
5Y-17.117-9.713-7.404
10Y-127.846-7.673-120.173
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Braster.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Braster S.A.:

  • The MRQ is -26.726. Very Bad. -2
  • The TTM is -5.557. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-26.726TTM-5.557-21.169
TTM-5.557YOY-20.593+15.036
TTM-5.5575Y-13.717+8.160
5Y-13.71710Y-241.259+227.542
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.7260.013-26.739
TTM-5.5570.046-5.603
YOY-20.5930.027-20.620
5Y-13.7170.068-13.785
10Y-241.2590.047-241.306

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Braster is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 34.81 means the investor is paying zł34.81 for each zł1 in book value.

Let's take a look of the Price to Book Ratio trends of Braster S.A.:

  • The EOD is 34.998. Seems overpriced? -1
  • The MRQ is 34.809. Seems overpriced? -1
  • The TTM is 18.998. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD34.998MRQ34.809+0.189
MRQ34.809TTM18.998+15.811
TTM18.998YOY4.399+14.599
TTM18.9985Y5.950+13.048
5Y5.95010Y13.825-7.875
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD34.9982.196+32.802
MRQ34.8092.474+32.335
TTM18.9983.559+15.439
YOY4.3994.220+0.179
5Y5.9503.471+2.479
10Y13.8253.042+10.783
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Braster S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.030-0.032+5%-0.120+299%-0.099+226%0.001-5239%
Book Value Growth--0.4120.682-40%0.878-53%0.859-52%1.097-62%
Book Value Per Share--0.0210.053-60%0.289-93%0.663-97%0.811-97%
Book Value Per Share Growth--0.4120.682-40%0.878-53%0.859-52%1.097-62%
Current Ratio--0.3260.346-6%0.529-38%1.018-68%2.711-88%
Debt To Asset Ratio--0.9750.937+4%0.787+24%0.645+51%0.468+108%
Debt To Equity Ratio--38.65219.069+103%4.476+764%5.357+622%3.161+1123%
Dividend Per Share----0%-0%-0%-0%
Eps---0.030-0.047+57%-0.128+323%-0.121+302%-0.108+259%
Eps Growth--0.9120.872+5%-0.122+113%0.804+14%0.799+14%
Free Cash Flow Per Share--0.008-0.020+357%-0.018+328%-0.112+1538%-0.143+1935%
Free Cash Flow Per Share Growth--2.109-0.725+134%1.008+109%0.515+310%0.563+275%
Free Cash Flow To Equity Per Share--0.0080.003+146%-0.007+195%-0.075+1060%-0.015+289%
Free Cash Flow To Equity Per Share Growth--3.9645.997-34%0.607+553%2.117+87%2.342+69%
Gross Profit Margin--1.0471.074-2%1.080-3%1.117-6%1.089-4%
Intrinsic Value_10Y_max---3.043--------
Intrinsic Value_10Y_min---11.101--------
Intrinsic Value_1Y_max---0.113--------
Intrinsic Value_1Y_min---0.419--------
Intrinsic Value_3Y_max---0.485--------
Intrinsic Value_3Y_min---1.866--------
Intrinsic Value_5Y_max---1.034--------
Intrinsic Value_5Y_min---3.969--------
Net Profit Margin---1.018-13.089+1186%-127.222+12396%-50.931+4903%-36.200+3456%
Operating Margin---0.608-10.661+1652%-117.516+19215%-46.469+7538%-33.698+5439%
Operating Ratio--1.4844.554-67%34.843-96%28.367-95%23.327-94%
Pb Ratio34.998+1%34.80918.998+83%4.399+691%5.950+485%13.825+152%
Pe Ratio-24.519-1%-24.387-20.646-15%-20.493-16%-17.117-30%-127.846+424%
Peg Ratio---26.726-5.557-79%-20.593-23%-13.717-49%-241.259+803%
Price Per Share0.740+1%0.7360.826-11%1.069-31%1.870-61%7.339-90%
Price To Total Gains Ratio-24.519-1%-24.387-1.589-93%-6.217-75%-24.053-1%-98.282+303%
Profit Growth--0.9120.872+5%-0.122+113%0.804+14%0.799+14%
Quick Ratio--0.0510.044+14%0.087-41%0.403-87%1.873-97%
Return On Assets---0.036-0.056+56%-0.100+177%-0.075+108%-0.075+110%
Return On Equity---1.427-0.980-31%-0.497-65%-0.384-73%-0.263-82%
Revenue Growth--5.1882.369+119%3.380+53%1.853+180%1.715+203%
Total Gains Per Share---0.030-0.032+5%-0.120+299%-0.099+226%0.001-5239%
Total Gains Per Share Growth--0.8410.228+268%-38.571+4687%-7.051+939%-2.321+376%
Usd Book Value--136456.000343445.000-60%1868317.750-93%4281118.948-97%5236595.123-97%
Usd Book Value Change Per Share---0.007-0.007+5%-0.028+299%-0.023+226%0.000-5239%
Usd Book Value Per Share--0.0050.012-60%0.067-93%0.153-97%0.187-97%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.007-0.011+57%-0.029+323%-0.028+302%-0.025+259%
Usd Free Cash Flow--50249.000-129368.125+357%-114584.992+328%-722495.047+1538%-922012.664+1935%
Usd Free Cash Flow Per Share--0.002-0.005+357%-0.004+328%-0.026+1538%-0.033+1935%
Usd Free Cash Flow To Equity Per Share--0.0020.001+146%-0.002+195%-0.017+1060%-0.003+289%
Usd Price Per Share0.171+1%0.1700.190-11%0.246-31%0.431-61%1.692-90%
Usd Profit---194772.500-305988.750+57%-823651.076+323%-782547.500+302%-699085.998+259%
Usd Revenue--191315.00069265.250+176%22701.258+743%39277.200+387%25848.014+640%
Usd Total Gains Per Share---0.007-0.007+5%-0.028+299%-0.023+226%0.000-5239%
 EOD+2 -3MRQTTM+26 -14YOY+26 -145Y+26 -1410Y+21 -19

3.2. Fundamental Score

Let's check the fundamental score of Braster S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-24.519
Price to Book Ratio (EOD)Between0-134.998
Net Profit Margin (MRQ)Greater than0-1.018
Operating Margin (MRQ)Greater than0-0.608
Quick Ratio (MRQ)Greater than10.051
Current Ratio (MRQ)Greater than10.326
Debt to Asset Ratio (MRQ)Less than10.975
Debt to Equity Ratio (MRQ)Less than138.652
Return on Equity (MRQ)Greater than0.15-1.427
Return on Assets (MRQ)Greater than0.05-0.036
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Braster S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.388
Ma 20Greater thanMa 500.750
Ma 50Greater thanMa 1000.768
Ma 100Greater thanMa 2000.762
OpenGreater thanClose0.742
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-09-302021-12-312022-03-312022-06-302022-09-30
EBITDA  -172-1,418-1,5901,154-436172-26432864



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in PLN. All numbers in thousands.

Summary
Total Assets23,474
Total Liabilities22,882
Total Stockholder Equity592
 As reported
Total Liabilities 22,882
Total Stockholder Equity+ 592
Total Assets = 23,474

Assets

Total Assets23,474
Total Current Assets6,118
Long-term Assets6,118
Total Current Assets
Cash And Cash Equivalents 393
Net Receivables 558
Inventory 5,167
Total Current Assets  (as reported)6,118
Total Current Assets  (calculated)6,118
+/-0
Long-term Assets
Property Plant Equipment 11,386
Intangible Assets 2,281
Long-term Assets Other 3,689
Long-term Assets  (as reported)17,356
Long-term Assets  (calculated)17,356
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,766
Long-term Liabilities4,116
Total Stockholder Equity592
Total Current Liabilities
Short-term Debt 11,956
Short Long Term Debt 11,956
Accounts payable 1,473
Other Current Liabilities 4,720
Total Current Liabilities  (as reported)18,766
Total Current Liabilities  (calculated)30,105
+/- 11,339
Long-term Liabilities
Other Liabilities 4,118
Long-term Liabilities  (as reported)4,116
Long-term Liabilities  (calculated)4,118
+/- 2
Total Stockholder Equity
Common Stock2,756
Retained Earnings -113,638
Other Stockholders Equity 111,474
Total Stockholder Equity (as reported)592
Total Stockholder Equity (calculated)592
+/-0
Other
Capital Stock2,756
Cash and Short Term Investments 393
Common Stock Shares Outstanding 27,998
Liabilities and Stockholders Equity 23,474
Net Debt 11,563
Net Invested Capital 12,548
Net Tangible Assets -337
Net Working Capital -12,648
Short Long Term Debt Total 11,956



Balance Sheet

Currency in PLN. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
0
0
0
6,352
5,696
11,262
13,393
13,623
16,302
49,499
48,684
47,667
46,446
51,721
50,044
64,835
56,653
50,606
78,842
73,607
66,909
63,081
57,842
54,528
49,345
47,180
48,831
48,866
45,938
45,105
44,788
35,877
42,771
33,933
33,081
23,737
23,366
23,551
23,474
23,47423,55123,36623,73733,08133,93342,77135,87744,78845,10545,93848,86648,83147,18049,34554,52857,84263,08166,90973,60778,84250,60656,65364,83550,04451,72146,44647,66748,68449,49916,30213,62313,39311,2625,6966,352000
   > Total Current Assets 
0
0
0
3,685
3,073
8,492
10,278
10,509
12,554
42,771
37,999
31,576
28,167
31,466
25,352
25,931
18,473
9,589
38,291
36,801
30,184
26,717
21,990
19,403
14,902
13,338
15,231
15,372
12,910
12,917
13,448
12,747
12,740
12,660
12,676
5,934
6,199
6,307
6,118
6,1186,3076,1995,93412,67612,66012,74012,74713,44812,91712,91015,37215,23113,33814,90219,40321,99026,71730,18436,80138,2919,58918,47325,93125,35231,46628,16731,57637,99942,77112,55410,50910,2788,4923,0733,685000
       Cash And Cash Equivalents 
0
0
0
2,870
1,928
6,665
8,524
7,978
9,639
39,155
33,066
25,578
23,331
25,636
12,844
17,396
8,237
2,498
31,037
25,108
19,505
14,584
9,916
5,393
1,944
176
2,095
2,274
305
113
683
119
54
41
15
27
261
151
393
393151261271541541196831133052,2742,0951761,9445,3939,91614,58419,50525,10831,0372,4988,23717,39612,84425,63623,33125,57833,06639,1559,6397,9788,5246,6651,9282,870000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
164
0
0
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001700016416200000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124
71
74
49
68
317
344
365
7,267
455
550
767
558
5587675504557,2673653443176849747112400000000000000000000000000
       Other Current Assets 
0
0
0
815
1,145
1,827
1,753
2,531
2,915
3,616
4,933
5,998
4,836
5,712
12,281
7,459
9,585
6,106
6,198
10,885
9,472
10,878
10,692
9,771
8,471
8,523
7,473
7,560
7,335
7,242
7,203
7,201
7,217
7,224
7,267
496
550
797
558
5587975504967,2677,2247,2177,2017,2037,2427,3357,5607,4738,5238,4719,77110,69210,8789,47210,8856,1986,1069,5857,45912,2815,7124,8365,9984,9333,6162,9152,5311,7531,8271,145815000
   > Long-term Assets 
0
0
0
2,667
2,623
2,770
3,115
3,114
3,748
6,728
10,685
16,091
18,279
20,255
24,692
38,904
38,180
41,017
40,551
36,806
36,725
36,364
35,852
35,125
34,443
33,842
33,600
33,494
33,027
32,188
31,340
23,130
30,031
21,273
20,405
17,803
17,167
17,244
17,356
17,35617,24417,16717,80320,40521,27330,03123,13031,34032,18833,02733,49433,60033,84234,44335,12535,85236,36436,72536,80640,55141,01738,18038,90424,69220,25518,27916,09110,6856,7283,7483,1143,1152,7702,6232,667000
       Property Plant Equipment 
0
0
0
1,399
1,394
1,396
1,528
1,541
2,055
4,955
8,908
14,223
16,238
17,708
21,754
22,393
22,323
22,151
22,048
22,001
21,270
21,424
21,482
20,691
20,462
20,232
20,003
20,142
19,905
19,681
19,457
14,447
19,085
14,012
13,798
11,930
11,739
11,602
11,386
11,38611,60211,73911,93013,79814,01219,08514,44719,45719,68119,90520,14220,00320,23220,46220,69121,48221,42421,27022,00122,04822,15122,32322,39321,75417,70816,23814,2238,9084,9552,0551,5411,5281,3961,3941,399000
       Intangible Assets 
0
0
0
1,178
1,168
1,312
1,524
1,229
1,238
1,172
1,125
1,275
1,449
1,485
1,897
15,399
14,760
14,131
13,758
13,555
14,201
13,690
13,106
13,171
12,642
12,073
11,561
10,906
10,312
9,720
9,126
5,569
7,876
4,221
3,597
3,155
2,710
2,670
2,281
2,2812,6702,7103,1553,5974,2217,8765,5699,1269,72010,31210,90611,56112,07312,64213,17113,10613,69014,20113,55513,75814,13114,76015,3991,8971,4851,4491,2751,1251,1721,2381,2291,5241,3121,1681,178000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,981
2,391
2,780
2,729
2,700
5,645
8,768
5,315
3,190
3,915
4,182
4,091
5,042
5,0424,0914,1823,9153,1905,3158,7685,6452,7002,7292,7802,3911,98100000000000000000000000000
> Total Liabilities 
0
0
0
431
441
688
4,095
4,811
8,624
5,301
5,801
5,668
6,291
6,427
8,250
29,995
27,550
27,768
23,085
24,810
23,490
24,814
24,250
25,513
24,749
26,033
30,239
28,079
26,343
27,437
27,181
27,974
27,567
28,755
28,944
21,972
21,200
22,114
22,882
22,88222,11421,20021,97228,94428,75527,56727,97427,18127,43726,34328,07930,23926,03324,74925,51324,25024,81423,49024,81023,08527,76827,55029,9958,2506,4276,2915,6685,8015,3018,6244,8114,095688441431000
   > Total Current Liabilities 
0
0
0
451
440
685
4,093
4,811
8,625
5,321
5,863
5,707
6,286
6,487
8,271
12,753
6,822
11,247
6,937
8,488
7,451
19,263
18,841
20,549
19,860
13,441
18,564
23,402
21,718
22,910
22,732
23,596
23,265
24,504
24,776
17,386
16,934
17,910
18,766
18,76617,91016,93417,38624,77624,50423,26523,59622,73222,91021,71823,40218,56413,44119,86020,54918,84119,2637,4518,4886,93711,2476,82212,7538,2716,4876,2865,7075,8635,3218,6254,8114,093685440451000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
7
0
399
678
1,355
1,369
1,446
1,446
11,855
11,937
11,835
11,512
4,307
9,195
12,673
11,534
11,849
11,849
11,994
11,560
11,993
12,293
11,954
12,574
12,717
11,956
11,95612,71712,57411,95412,29311,99311,56011,99411,84911,84911,53412,6739,1954,30711,51211,83511,93711,8551,4461,4461,3691,355678399070000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,560
11,993
12,293
11,954
12,574
12,717
11,956
11,95612,71712,57411,95412,29311,99311,56000000000000000000000000000000000
       Accounts payable 
0
0
0
116
105
382
103
224
136
253
741
254
866
804
2,282
2,557
481
851
708
1,685
679
790
610
910
607
1,436
981
1,601
1,250
1,392
1,290
1,182
1,231
1,338
1,213
1,182
1,282
1,755
1,473
1,4731,7551,2821,1821,2131,3381,2311,1821,2901,3921,2501,6019811,4366079106107906791,6857088514812,5572,282804866254741253136224103382105116000
       Other Current Liabilities 
0
0
0
335
296
263
3,955
4,540
4,984
5,012
5,054
5,368
5,295
5,514
5,853
9,620
5,484
8,860
4,669
5,167
5,137
6,408
6,129
7,624
7,564
7,411
7,983
8,782
8,681
9,206
9,233
9,532
9,592
10,246
10,361
3,329
2,045
2,528
4,720
4,7202,5282,0453,32910,36110,2469,5929,5329,2339,2068,6818,7827,9837,4117,5647,6246,1296,4085,1375,1674,6698,8605,4849,6205,8535,5145,2955,3685,0545,0124,9844,5403,955263296335000
   > Long-term Liabilities 
0
0
0
-20
0
2
1
0
-1
-20
-62
-39
5
-60
-21
17,242
20,728
16,521
16,148
16,322
16,039
5,551
5,409
4,964
4,889
12,592
11,675
4,677
4,625
4,528
4,449
4,378
4,302
4,251
4,168
4,586
4,266
4,204
4,116
4,1164,2044,2664,5864,1684,2514,3024,3784,4494,5284,6254,67711,67512,5924,8894,9645,4095,55116,03916,32216,14816,52120,72817,242-21-605-39-62-20-10120-20000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,377
4,304
4,248
4,166
4,414
4,265
4,189
4,118
4,1184,1894,2654,4144,1664,2484,3044,3770000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,902
5,517
2,096
0
1,676
1,464
1,560
1,352
1,3521,5601,4641,67602,0965,5172,9020000000000000000000000000000000
> Total Stockholder Equity
0
0
0
5,921
5,255
10,574
9,298
8,812
7,678
44,198
42,883
41,999
40,155
45,294
41,794
34,840
29,103
22,838
55,757
48,797
43,419
38,267
33,592
29,015
24,596
21,147
18,592
20,787
19,594
17,668
17,607
7,903
15,204
5,178
4,137
1,765
2,166
1,437
592
5921,4372,1661,7654,1375,17815,2047,90317,60717,66819,59420,78718,59221,14724,59629,01533,59238,26743,41948,79755,75722,83829,10334,84041,79445,29440,15541,99942,88344,1987,6788,8129,29810,5745,2555,921000
   Common Stock
0
0
0
250
250
300
300
300
301
561
561
561
561
617
617
617
617
617
917
917
917
917
917
917
917
917
1,079
1,903
2,226
1,948
2,226
2,226
2,529
2,529
2,529
2,529
2,744
2,529
2,756
2,7562,5292,7442,5292,5292,5292,5292,2262,2261,9482,2261,9031,079917917917917917917917917617617617617617561561561561301300300300250250000
   Retained Earnings Total Equity000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
107,573
106,958
107,780
0
109,847
109,847
109,847
0
0
0
0
0000109,847109,847109,8470107,780106,958107,5730000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
11,571
11,571
17,663
17,626
17,816
17,814
54,906
54,756
54,756
54,756
61,929
61,929
61,929
61,929
61,929
100,478
100,478
100,478
100,478
100,478
100,478
100,478
100,478
102,027
106,802
107,573
108,058
109,327
109,598
109,933
109,847
109,847
109,847
111,437
111,700
111,474
111,474111,700111,437109,847109,847109,847109,933109,598109,327108,058107,573106,802102,027100,478100,478100,478100,478100,478100,478100,478100,47861,92961,92961,92961,92961,92954,75654,75654,75654,90617,81417,81617,62617,66311,57111,571000



Balance Sheet

Currency in PLN. All numbers in thousands.




Cash Flow

Currency in PLN. All numbers in thousands.




Income Statement

Currency in PLN. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue436
Cost of Revenue-413
Gross Profit2323
 
Operating Income (+$)
Gross Profit23
Operating Expense-4,295
Operating Income-6,107-4,272
 
Operating Expense (+$)
Research Development-
Selling General Administrative3,625
Selling And Marketing Expenses494
Operating Expense4,2954,119
 
Net Interest Income (+$)
Interest Income0
Interest Expense-580
Net Interest Income-583-580
 
Pretax Income (+$)
Operating Income-6,107
Net Interest Income-583
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-6,690-5,524
EBIT - interestExpense = -6,690
-6,690
-6,110
Interest Expense580
Earnings Before Interest and Taxes (ebit)-6,110-6,110
Earnings Before Interest and Taxes (ebitda)-3,073
 
After tax Income (+$)
Income Before Tax-6,690
Tax Provision-0
Net Income From Continuing Ops-6,690-6,690
Net Income-6,690
Net Income Applicable To Common Shares-6,690
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses4,708
Total Other Income/Expenses Net-583583
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ICG.VN
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ICG.VN.

ICG.VN Daily Candlestick Chart
PNJ.VN
9 minutes ago

I found you a MACD Bullish Reversal Divergence on the daily chart of PNJ.VN.

PNJ.VN Daily Candlestick Chart
ICT.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ICT.AU.

ICT.AU Daily Candlestick Chart
CEI.PSE
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CEI.PSE.

CEI.PSE Daily Candlestick Chart
VUL.PSE
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of VUL.PSE.

VUL.PSE Daily Candlestick Chart
PHA.PSE
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PHA.PSE.

PHA.PSE Daily Candlestick Chart
CIP.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CIP.AU.

CIP.AU Daily Candlestick Chart
CGC.AU
1 hour ago

I found you a Golden Cross on the daily chart of CGC.AU.

CGC.AU Daily Candlestick Chart
CCP.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCP.AU.

CCP.AU Daily Candlestick Chart
JGS.PSE
1 hour ago

I found you a Golden Cross on the daily chart of JGS.PSE.

JGS.PSE Daily Candlestick Chart
EW.PSE
1 hour ago

I found you a Golden Cross on the daily chart of EW.PSE.

EW.PSE Daily Candlestick Chart
CHP.PSE
1 hour ago

I found you a Golden Cross on the daily chart of CHP.PSE.

CHP.PSE Daily Candlestick Chart
BLG.AU
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of BLG.AU.

BLG.AU Daily Candlestick Chart
BAS.AU
1 hour ago

I found you a RSI Bullish Hidden Divergence on the daily chart of BAS.AU.

BAS.AU Daily Candlestick Chart
ATA.AU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ATA.AU.

ATA.AU Daily Candlestick Chart
ARR.AU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ARR.AU.

ARR.AU Daily Candlestick Chart
ARG.AU
2 hours ago

I found you a Golden Cross on the daily chart of ARG.AU.

ARG.AU Daily Candlestick Chart
AQC.AU
2 hours ago

I found you a Death Cross on the daily chart of AQC.AU.

AQC.AU Daily Candlestick Chart
AMX.AU
2 hours ago

I found you a RSI Bearish Reversal Divergence on the daily chart of AMX.AU.

AMX.AU Daily Candlestick Chart
AKP.AU
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AKP.AU.

AKP.AU Daily Candlestick Chart
ADH.AU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADH.AU.

ADH.AU Daily Candlestick Chart
ABP.AU
2 hours ago

I found you a Golden Cross on the daily chart of ABP.AU.

ABP.AU Daily Candlestick Chart
WAM.AU
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WAM.AU.

WAM.AU Daily Candlestick Chart
VR8.AU
2 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VR8.AU.

VR8.AU Daily Candlestick Chart